Navigation Links
Angiotech to participate in Lehman Brothers Healthcare Conference
Date:3/17/2008

VANCOUVER, March 17 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, is scheduled to participate in the Lehman Brothers Eleventh Annual Global Healthcare Conference, which is being held March 18-20 in Miami Beach, Florida.

Dr. William Hunter, Angiotech's President and Chief Executive Officer, is scheduled to present on Thursday, March 20, beginning at approximately 10:45 am ET. A question and answer session will immediately follow the presentation.

A live webcast of Dr. Hunter's remarks and the question and answer session will be available to all interested parties on the company's website, http://www.angiotech.com, under the Investors section.

About Angiotech

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP), please visit our website at http://www.angiotech.com.

CONTACT: Deirdre Neary, Manager, Investor Relations, Angiotech Pharmaceuticals, Inc., (604) 222-7056, dneary@angio.com


'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006
2. Angiotech and Rex Medical announce exclusive licensing and distribution agreement for the "Option(TM)" inferior vena cava filter
3. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
4. Angiotech announces results for the fourth quarter ended December 31, 2007
5. Angiotech to participate in Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Angiotech Pharmaceuticals, Inc. - Notice of Conference Call and Webcast
7. Angiotech and Symphony Medical Announce Licensing Agreement
8. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
9. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
10. Angiotech to participate in RBC 2007 Healthcare Conference
11. Angiotech to participate in Bank of America 2007 Credit Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... , Jan 13, 2017 Research and Markets ... Manufacturing, Application - Global Forecast to 2021" report to their ... The ... from USD 3.39 Billion in 2016, at a CAGR of 26.3%. ... basis of product, manufacturing type, and application. Factors such as rising ...
(Date:1/13/2017)... ... January 13, 2017 , ... Two Kalamazoo entrepreneurs ... called fulvic acid that farms, greenhouses and hydroponics operations use to increase yields ... the fastest growing segments of customers using this high grade fulvic acid extracted ...
(Date:1/13/2017)... ... January 13, 2017 , ... ... companies to offer its customers three new solutions for measurements where traditional cuvette ... handy if a customer has an oddly-shaped sample that would not fit into ...
(Date:1/12/2017)... ... , ... Each year, Crain’s Detroit Business News ranks the most innovative companies ... estate of a company, its impact and significance, and the likelihood of bringing it ... technologies that transform energy sources such as low dose X-ray and convert them into ...
Breaking Biology Technology:
(Date:12/15/2016)... 2016 ... Research and Markets has announced the addition of the ... The report forecasts the global military biometrics market to grow at ... report has been prepared based on an in-depth market analysis with inputs ... prospects over the coming years. The report also includes a discussion of ...
(Date:12/12/2016)... 2016  Researchers at Trinity College, Dublin, are ... combining the material with Silly Putty. The mixture (known ... able to sense pulse, blood pressure, respiration, and ... The research team,s findings were published ... http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... December 7, 2016 BioCatch , the global ... its patent portfolio, which grew to over 40 granted and pending patents. ... , , ... patent entitled " System, Device, and Method Estimating Force Applied ... device makers to forego costly hardware components needed to estimate the force ...
Breaking Biology News(10 mins):